205 related articles for article (PubMed ID: 20809202)
1. The role of FSH and TSH in bone loss and its clinical relevance.
Agrawal M; Zhu G; Sun L; Zaidi M; Iqbal J
Curr Osteoporos Rep; 2010 Dec; 8(4):205-11. PubMed ID: 20809202
[TBL] [Abstract][Full Text] [Related]
2. Newly reported roles of thyroid-stimulating hormone and follicle-stimulating hormone in bone remodelling.
Sendak RA; Sampath TK; McPherson JM
Int Orthop; 2007 Dec; 31(6):753-7. PubMed ID: 17611756
[TBL] [Abstract][Full Text] [Related]
3. [Hormones and osteoporosis update. Possible roles of pituitary hormones, TSH and FSH, for bone metabolism].
Takeuchi Y
Clin Calcium; 2009 Jul; 19(7):977-83. PubMed ID: 19567994
[TBL] [Abstract][Full Text] [Related]
4. Thyroid-stimulating hormone, thyroid hormones, and bone loss.
Zaidi M; Davies TF; Zallone A; Blair HC; Iqbal J; Moonga SS; Mechanick J; Sun L
Curr Osteoporos Rep; 2009 Jul; 7(2):47-52. PubMed ID: 19631028
[TBL] [Abstract][Full Text] [Related]
5. Hyperthyroid-associated osteoporosis is exacerbated by the loss of TSH signaling.
Baliram R; Sun L; Cao J; Li J; Latif R; Huber AK; Yuen T; Blair HC; Zaidi M; Davies TF
J Clin Invest; 2012 Oct; 122(10):3737-41. PubMed ID: 22996689
[TBL] [Abstract][Full Text] [Related]
6. FSH and TSH in the regulation of bone mass: the pituitary/immune/bone axis.
Colaianni G; Cuscito C; Colucci S
Clin Dev Immunol; 2013; 2013():382698. PubMed ID: 23818914
[TBL] [Abstract][Full Text] [Related]
7. TSH is a negative regulator of skeletal remodeling.
Abe E; Marians RC; Yu W; Wu XB; Ando T; Li Y; Iqbal J; Eldeiry L; Rajendren G; Blair HC; Davies TF; Zaidi M
Cell; 2003 Oct; 115(2):151-62. PubMed ID: 14567913
[TBL] [Abstract][Full Text] [Related]
8. Effects of thyroid status on bone metabolism: a primary role for thyroid stimulating hormone or thyroid hormone?
Galliford TM; Murphy E; Williams AJ; Bassett JH; Williams GR
Minerva Endocrinol; 2005 Dec; 30(4):237-46. PubMed ID: 16319811
[TBL] [Abstract][Full Text] [Related]
9. [Control of bone remodeling by nervous system. Possible roles of pituitary hormones for bone metabolism].
Takeuchi Y
Clin Calcium; 2010 Dec; 20(12):1857-64. PubMed ID: 21123938
[TBL] [Abstract][Full Text] [Related]
10. TSH and bone loss.
Sun L; Davies TF; Blair HC; Abe E; Zaidi M
Ann N Y Acad Sci; 2006 Apr; 1068():309-18. PubMed ID: 16831931
[TBL] [Abstract][Full Text] [Related]
11. Actions of pituitary hormones beyond traditional targets.
Zaidi M; New MI; Blair HC; Zallone A; Baliram R; Davies TF; Cardozo C; Iqbal J; Sun L; Rosen CJ; Yuen T
J Endocrinol; 2018 Jun; 237(3):R83-R98. PubMed ID: 29555849
[TBL] [Abstract][Full Text] [Related]
12. Paradigm shift in the pathophysiology of postmenopausal and thyrotoxic osteoporosis.
Zaidi M; Iqbal J; Blair HC; Zallone A; Davies T; Sun L
Mt Sinai J Med; 2009 Oct; 76(5):474-83. PubMed ID: 19787657
[TBL] [Abstract][Full Text] [Related]
13. Changes in bone mass during the perimenopausal transition in naturally menopausal cynomolgus monkeys.
Kittivanichkul D; Watanabe G; Nagaoka K; Malaivijitnond S
Menopause; 2016 Jan; 23(1):87-99. PubMed ID: 26671190
[TBL] [Abstract][Full Text] [Related]
14. The Relationship between Follicle-stimulating Hormone and Bone Health: Alternative Explanation for Bone Loss beyond Oestrogen?
Chin KY
Int J Med Sci; 2018; 15(12):1373-1383. PubMed ID: 30275766
[TBL] [Abstract][Full Text] [Related]
15. Follicle-stimulating hormone and estradiol are associated with bone mineral density and risk of fractures in men with type 2 diabetes mellitus.
Jing Y; Wang X; Yu J; Wang X; Zhou Y; Tao B; Sun L; Liu J; Zhao H
J Diabetes; 2020 Jun; 12(6):426-437. PubMed ID: 31778286
[TBL] [Abstract][Full Text] [Related]
16. Follicle-stimulating hormone increases bone mass in female mice.
Allan CM; Kalak R; Dunstan CR; McTavish KJ; Zhou H; Handelsman DJ; Seibel MJ
Proc Natl Acad Sci U S A; 2010 Dec; 107(52):22629-34. PubMed ID: 21149714
[TBL] [Abstract][Full Text] [Related]
17. [Bone metabolism by sex hormones and gonadotropins].
Imai Y
Clin Calcium; 2014 Jun; 24(6):815-9. PubMed ID: 24870831
[TBL] [Abstract][Full Text] [Related]
18. New insights: elevated follicle-stimulating hormone and bone loss during the menopausal transition.
Zaidi M; Blair HC; Iqbal J; Davies TF; Zhu LL; Zallone A; Sun L
Curr Rheumatol Rep; 2009 Jul; 11(3):191-5. PubMed ID: 19604463
[TBL] [Abstract][Full Text] [Related]
19. Pituitary dysfunction in recently post-menopausal women. Nottingham EPIC Study Group.
Lyons A; Ng C; Fielding K; Hosking D; Selby C; Lawson N
Clin Endocrinol (Oxf); 1997 Oct; 47(4):431-8. PubMed ID: 9404441
[TBL] [Abstract][Full Text] [Related]
20. Low Thyroid Stimulating Hormone Levels Are Associated with Low Bone Mineral Density in Femoral Neck in Elderly Women.
Ding B; Zhang Y; Li Q; Hu Y; Tao XJ; Liu BL; Ma JH; Li DM
Arch Med Res; 2016 May; 47(4):310-4. PubMed ID: 27664492
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
